17
Views
3
CrossRef citations to date
0
Altmetric
Review

Preference assessment in patients with asthma

&
Pages 607-618 | Published online: 09 Jan 2014

References

  • Bennett KJ, Torrance GW. Measuring health preferences and utilities: rating scale, time trade-off and standard gamble methods. In: Quality of Life and Phannacoeconomics in Clinical Bids. Spilker B (Ed.), Lippincott-Raven, Philadelphia, PA, USA, 253–265 (1996).
  • ••Excellent overview of preference measurement particularly related to the standard gamble, time trade-off and VAS methods.
  • Drummond ME, O'Brien B, Stoddart GL, Torrance GW. Methods For The Economic Evaluation Of Healthcair Programmes. Oxford University Press, Oxford, UK (1997).
  • ••Required resource for anyone interested in economic evaluations, great chapter on cost-utility analysis that includes a discussion of preference-based instruments.
  • Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness In Health And Medicine. Oxford University Press, New York, NY, USA (1996).
  • •Describes the US panel on cost-effectiveness in health and medicine recommendations regarding preference measurement and briefly discusses preference instruments.
  • von Neumann J, Morgenstern 0. Theory Of Games And Economic Behavior Princeton University Press, Princeton, NJ, USA (1944).
  • Torrance GVV, Feeny D, Furlong W Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis. Making21(4), 329–334 (2001).
  • •Paper discusses the measurement biases and other limitations of the VAS.
  • Kaplan PM, Anderson JP. A general health policy model: update and applications. Health Serv Res. 23(2), 203–235 (1988).
  • EuroQol — a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16(3), 199–208 (1990).
  • •Describes the development of the EQ-5D.
  • Dolan P Modeling valuations for EuroQol health states. Med. Cate. 35(11), 1095–1108 (1997).
  • •Description of the UK-based scoring algorithm for the EQ-5D.
  • Feeny D, Furlong W Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. PhannacoEconomics 7(6), 490–502 (1995).
  • Feeny DH, Torrance GVV, Furlong WJ. Health Utilities Index. In: Quality of Life and Phannacoeconomks in Clinical Bids. Spilker B (Ed.), Lippincott-Raven, Philadelphia, PA, USA, 239–252 (1996).
  • Furlong W Feeny D, Torrance GW et al. Multiplicative Multi-Attribute Utility Function for the HUT Mark 3 (H11I3) System: A Technical Report. McMaster University Centre for Health Economics and Policy Analysis Working Paper No. 98-11, Ontario, Canada (1998).
  • •Working paper that describes the HUI3.
  • Torrance GVV, Furlong W Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. PhannacoEconomics 7(6), 503–520 (1995).
  • •Describes multiattribute utility theory and how it was applied to estimate preference weights for the I-11JI2 and HUI3.
  • Torrance GVV, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med. Care. 34(7), 702–722 (1996).
  • •Describes the HUI2.
  • Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J. Clin. Epidemiol 51(11), 1115–1128 (1998).
  • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Health Econ. 21, 271–292 (2002).
  • •Methods paper on the development of the most recent iteration of the SF-6D.
  • Fryback DG, Lawrence WF, Martin PA, Klein R, Klein BE. Predicting Quality of Well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med arA Making17 (1), 1–9 (1997).
  • Lundberg L, Johannesson M, Isacson DG, Borgquist L. The relationship between health-state utilities and the SF-12 in a general population. Med. Decis. Making 19(2), 128–140 (1999).
  • Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (H11I2) from the SF-36. Med Decis. Making21 (2), 105–112 (2001).
  • Shmueli A. Subjective health status and health values in the general population. Med Beds. Making19(2), 122–127(1999).
  • Hollingworth W Deyo RA, Sullivan SD, Emerson SS, Gray DT, Jarvik JG. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Health Econ. 11(1), 71–85 (2002).
  • Lee TA, Hollingworth W Sullivan SD. Directly elicited preference compared to preferences derived from the SF-36 in adult asthmatics. Proceedings of the International Society for Pharmacoeconomics and Outcomes Research Seventh Annual International Meeting, Arlington, VA, USA, May 19–22, AR2. Value Health 5(3), 134–135 (2002).
  • Sherbourne CD, Unutzer J, Schoenbaum M etal. Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Med Care 39(11), 1246–1259 (2001).
  • Chiou CF, Weaver M, Bell M. Outcome assessment in pediatric asthma: a comparison of symptom-free time and multi-attribute scale. Proceedings of the International Society for Pharmacoeconomics and Outcomes Research Sixth Annual International Meeting. Arlington, VA, USA, May 20–23, RS1. Value Health 4(2), 64–65 (2001).
  • Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 114(4), 998–1007 (1998).
  • ••Description of the development andvalidation of the disease-specific, preference-based measure, the ASUI.
  • Neumann PJ, Blumenschein K, Zillich AJ etal. Relationship between FEVi% predicted and utilities in adult asthma. Proceedings of the 22nd Annual Meeting of the Society for Medical Decision Making. Cincinnati, OH, USA. Med. Decis. Making 20(4), 488 (2000).
  • Paltiel AD, Fuhlbrigge AL, Kitch BT etal Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J. Allergy Clin. Immunol. 108(1), 39–49 (2001).
  • Rutten-van Molken MP, Custers F, Van Doorslaer EK etal. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life [see comments]. Eur. Respir. 8(6), 888–898 (1995). First comparison of preference-based measures with disease-specific outcomes in asthma.
  • Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities and willingness to pay in patients with asthma. Ann. Allergy Asthma Immunol. 80(2), 189–194 (1998).
  • Burstrom K, Johannesson M, Diderichsen E Swedish population health-related quality of life results using the EQ- 5D. Qual. Life Res. 10(7), 621–635 (2001).
  • Mittmann N, Troikas K, Risebrough N, Liu BA. Utility scores for chronic conditions in a community-dwelling population. PharmacoEconomics 15 (4), 369–376 (1999).
  • Juniper EF, Norman GR, Cox FM, Roberts JN. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir. 18(1), 38–44 (2001). Evaluation of 'disease-specific' versions of the standard gamble and VAS.
  • Lee TA, Sullivan SD, Blough DK, Weiss K, Lim J, Ramsdell J. Comparison of outcome measures in a randomized trial of inhaled triamcinolone acetonide in adult asthmatics. Proceedings of the American Thoracic Society International Conference, San Diego, CA, USA (1999).
  • Leidy KN, Chan KS, Coughlin C. Is the asthma quality of life questionnaire a useful measure for low-income asthmatics? Am J. Respir. Grit. Care Med. 158(4), 1082–1090 (1998).
  • Juniper EF, Guyatt GH, Feeny DH, Griffith LE, Ferrie PJ. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Eur. Respir. 10(10), 2285–2294 (1997). Evaluation of the use of preference measurement instruments in older children.
  • Mutchler JE, Burr JA. Racial differences in health and healthcare service utilization in later life: the effect of socioeconomic status. J. Health Soc. Behav 32(4), 342–356 (1991).
  • Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB. National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care. Am. J. Respir. Grit. Care Med. 154(3 Pt 2), S84—S95 (1996).

Websites

  • EuroQol Group. Homepage of the EQ-5D: A generic measure of health status from the Eurociol Group. www.eurociol.org. Accessed August 26,2002.
  • Health Utilities, Inc. Health related quality of life. www.healthutilities.com. Accessed August 26,2002.
  • Health Utilities Group. Health Utilities Index and Quality of Life Research. www.fhs.mcmaster.ca/hug/ Accessed August 26,2002.
  • Sheffield Health Economics Group. SF-6D: estimating a preference-based index from the SF-36 for calculating QALYs. www.sheflac.uldsf-6c11 Accessed August 26, 2002.
  • Impact 3 Survey Generator. preferences.ucsd.eduiimpact32/aspi default.asp Accessed November 5,2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.